(AP) -- A panel of federal health experts voted unanimously in favor of a new eye drug from Regeneron, bringing the company one step closer to competing against a blockbuster Roche drug that currently dominates the market.
Jun 17, 2011
not rated yet
0
The first clinical trials that examine the use of stem cells to treat two forms of blindness are ready to begin now that patients have been enrolled, a US company announced on Thursday.
Jun 16, 2011
5 / 5 (1)
0
Newer treatments for age-related macular degeneration (AMD)—including an intravitreous (into the eye) injection of a chemotherapy drug and use of a related compound approved for use against the eye disease—do not ...
Oct 11, 2010
not rated yet
0
While 20/20 vision is a symbol of visual acuity, between now and the year 2020, more and more people will experience some extent of vision loss due to age-related macular degeneration (AMD) and other sight-robbing diseases.
Jul 01, 2010
1 / 5 (1)
0
found in red wine, grapes, blueberries, peanuts and other plants — stops out-of-control blood vessel growth in the eye, according to vision researchers at Washington University School of Medicine in St. ...
Jun 25, 2010
4.2 / 5 (5)
0
|
To get a better look at the abnormalities that cause age-related macular degeneration (AMD), the leading cause of vision loss in Americans and Europeans over 50, the research groups of James Fujimoto at the Massachusetts ...
Mar 19, 2009
not rated yet
0
